Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTR2A | P28223 | 1/20 | 0.56 |
| ▸ | IDO1 | P14902 | 2/20 | 0.50 |
| ▸ | HTT | P42858 | 2/20 | 0.50 |
| ▸ | RAB9A | P51151 | 1/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.49 |
| ▸ | MAOB | P27338 | 1/20 | 0.49 |
| ▸ | AKR1C3 | P42330 | 1/20 | 0.49 |
| ▸ | MAPT | P10636 | 1/20 | 0.47 |
| ▸ | POLB | P06746 | 1/20 | 0.47 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.47 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8247254 | 0.86 | HTR2A (0.60) | HTR2AIDO1HTTRAB9AALDH1A1 | |
| SCHEMBL29171050 | 0.84 | HTR2A (0.59) | HTR2AIDO1HTTRAB9AALDH1A1 | |
| SCHEMBL11098324 | 0.83 | HTR2A (0.58) | HTR2AIDO1HTTRAB9AALDH1A1 | |
| SCHEMBL11149132 | 0.82 | HTR2A (0.56) | HTR2AIDO1HTTRAB9AALDH1A1 | |
| SCHEMBL11147561 | 0.82 | HTR2A (0.56) | HTR2AIDO1HTTRAB9AALDH1A1 | |
| SCHEMBL9820376 | 0.81 | IDO1 (0.56) | HTR2AIDO1HTTRAB9AALDH1A1 | |
| SCHEMBL9782567 | 0.81 | IDO1 (0.56) | HTR2AIDO1HTTRAB9AALDH1A1 | |
| SCHEMBL11149224 | 0.81 | HTR2A (0.55) | HTR2AIDO1HTTRAB9AALDH1A1 | |
| SCHEMBL5724349 | 0.81 | HTR2A (0.55) | HTR2AIDO1HTTRAB9AALDH1A1 | |
| SCHEMBL27787126 | 0.81 | HTR2A (0.55) | HTR2AIDO1HTTRAB9AALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230374174-A1 | Circularly Recyclable Polymers Featuring Topochemically Elongated Carbon-Carbon Bonds | PURDUE RESEARCH FOUNDATION (US) | 2023-11-23 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230374174-A1 | Circularly Recyclable Polymers Featuring Topochemically Elongated Carbon-Carbon Bonds | PCNA, PARG, VIM | HTR2A 4437/4885IDO1 4333/4885HTT 978/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.